Fig. 2From: Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancerSurvival analysis of CDK9 protein expression in epithelial ovarian cancer (EOC). Kaplan-Meier survival analysis for the prognostic significance of CDK9 expression in EOC showed that patients with overexpression of CDK9 had reduced recurrence-free survival at 5 years compared to tumors showing low expression of CDK9 (p = 0.0122)Back to article page